Simulations Plus, Inc. Stock News

NEW YORK, July 26, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Simulations Plus, Inc. (NASDAQ: SLP) resulting from allegations that Simulations Plus may have issued materially misleading business information to the investing public.

ATLANTA, July 23, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Simulations Plus, Inc. (“Simulations Plus” or the “Company”) (NASDAQ: SLP) complied with federal securities laws. On July 14, 2025, Simulations Plus reported financial results for its third quarter fiscal 2025. The Company noted that it had recognized a one-time non-cash impairment charge of $77.2 million f...

Simulations Plus has recently declined after its Q3 2025 report, despite having a healthy revenue growth and adjusted EPS beat. This decline was mostly driven by a non‑cash impairment and lowered revenue guidance for 2025. The main culprit was their underperforming ALI/MC and QSP acquisitions and softer consulting services.

Image source: The Motley Fool.

Simulations Plus, Inc. (NASDAQ:SLP ) Q3 2025 Earnings Conference Call July 14, 2025 5:00 PM ET Company Participants Shawn M. O'Connor - Chief Executive Officer William Frederick - EVP & CFO Conference Call Participants Christine Rains - William Blair & Company L.L.C.

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced an investment of $1 million in technology company Nurocor. Founded in 2017, Nurocor offers a cloud-based sof...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today reported financial results for its third quarter fiscal 2025, ended May 31, 2025. Third Quarter 2025 ...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced that it has rescheduled the release of its financial results and conference call for the th...